These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 7543112)

  • 1. Does thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients' T cells to epitopes of thyrotropin receptor in autoimmune thyroid diseases?
    Soliman M; Kaplan E; Abdel-Latif A; Scherberg N; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2312-21. PubMed ID: 7543112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cells recognize multiple epitopes in the human thyrotropin receptor extracellular domain.
    Soliman M; Kaplan E; Yanagawa T; Hidaka Y; Fisfalen ME; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Mar; 80(3):905-14. PubMed ID: 7533773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of T lymphocyte subsets by synthetic TSH receptor peptides and recombinant glutamate decarboxylase in autoimmune thyroid disease and insulin-dependent diabetes.
    Mukuta T; Yoshikawa N; Arreaza G; Resetkova E; Leushner J; Song YH; Akasu F; Onaya T; Volpé R
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1264-72. PubMed ID: 7714099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy.
    Kung AW; Lau KS; Kohn LD
    Thyroid; 2000 Oct; 10(10):909-17. PubMed ID: 11081257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tale of radioiodine and Graves' orbitopathy.
    Ponto KA; Zang S; Kahaly GJ
    Thyroid; 2010 Jul; 20(7):785-93. PubMed ID: 20578895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma ELISPOT detecting reactivity of T cells to TSH receptor peptides in Graves' disease.
    Côté-Bigras S; Dionne A; Asselin-Mullen P; Leblicq C; Rottembourg D
    Clin Endocrinol (Oxf); 2014 Feb; 80(2):296-300. PubMed ID: 23734883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of oral tolerance in human autoimmune thyroid disease.
    Lee S; Scherberg N; DeGroot LJ
    Thyroid; 1998 Mar; 8(3):229-34. PubMed ID: 9545109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graves' disease in severe combined immunodeficient mice.
    Soliman M; Kaplan E; Straus F; Fisfalen ME; Hidaka Y; Guimaraes V; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2848-55. PubMed ID: 7559863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study.
    Brito JP; Payne S; Singh Ospina N; Rodriguez-Gutierrez R; Maraka S; Sangaralingham LR; Iñiguez-Ariza NM; Montori VM; Stan MN
    Thyroid; 2020 Mar; 30(3):357-364. PubMed ID: 31973681
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of Graves' hyperthyroidism: present and future.
    Bartalena L; Piantanida E; Gallo D; Ippolito S; Tanda ML
    Expert Rev Endocrinol Metab; 2022 Mar; 17(2):153-166. PubMed ID: 35287535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in epitopes for thyroid-stimulating antibodies in Graves' disease sera during treatment of hyperthyroidism: therapeutic implications.
    Kim WB; Chung HK; Lee HK; Kohn LD; Tahara K; Cho BY
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1953-9. PubMed ID: 9177413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired immune regulation after radioiodine therapy for Graves' disease and the protective effect of Methimazole.
    Côté-Bigras S; Tran V; Turcotte S; Rola-Pleszczynski M; Verreault J; Rottembourg D
    Endocrine; 2016 Jun; 52(3):587-96. PubMed ID: 26701678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Graves' Disease Patients Following Antithyroid Drugs, Radioactive Iodine, or Thyroidectomy as the First-line Treatment.
    Liu X; Wong CKH; Chan WWL; Tang EHM; Woo YC; Lam CLK; Lang BHH
    Ann Surg; 2021 Jun; 273(6):1197-1206. PubMed ID: 33914484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey.
    Törring O; Watt T; Sjölin G; Byström K; Abraham-Nordling M; Calissendorff J; Cramon PK; Filipsson Nyström H; Hallengren B; Holmberg M; Khamisi S; Lantz M; Wallin G
    Thyroid; 2019 Mar; 29(3):322-331. PubMed ID: 30667296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Prolonged Euthyroidism After Radioactive Iodine Treatment for Graves' Disease: A Pilot Study.
    Lu JY; Chen KH; Shih SR; Wen FY; Wu WC; Chen TC; Hu FC
    Endocr Pract; 2023 Feb; 29(2):89-96. PubMed ID: 36396015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Thyrotropin Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease.
    Kim J; Choi MS; Park J; Park H; Jang HW; Choe JH; Kim JH; Kim JS; Cho YS; Choi JY; Kim TH; Chung JH; Kim SW
    Thyroid; 2021 Aug; 31(8):1264-1271. PubMed ID: 33947272
    [No Abstract]   [Full Text] [Related]  

  • 17. A SURVEY OF CLINICAL PRACTICE PATTERNS IN MANAGEMENT OF GRAVES DISEASE IN THE MIDDLE EAST AND NORTH AFRICA.
    Beshyah SA; Khalil AB; Sherif IH; Benbarka MM; Raza SA; Hussein W; Alzahrani AS; Chadli A
    Endocr Pract; 2017 Mar; 23(3):299-308. PubMed ID: 27967219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group.
    Törring O; Tallstedt L; Wallin G; Lundell G; Ljunggren JG; Taube A; Sääf M; Hamberger B
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2986-93. PubMed ID: 8768863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell reactivity to recombinant human thyrotropin receptor extracellular domain and thyroglobulin in patients with autoimmune and nonautoimmune thyroid diseases.
    Soliman M; Kaplan E; Fisfalen ME; Okamoto Y; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Jan; 80(1):206-13. PubMed ID: 7829613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
    Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O
    Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.